Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile GlobeStar Therapeutics Corp GSTC

Healthcare Biotechnology
GlobeStar Therapeutics Corporation (GlobeStar Therapeutics) is a clinical-stage pharmaceutical company. The Company is focused on introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The Company owns the global license from the inventors, who are based in Italy.

Showcase News Releases

Showcase news

EnviroGold Global Limited.
EnviroGold Global Announces Outstanding Phase 3 Metallurgical Results from Major Tailings Reprocessing Projects
G Mining Ventures Corp.
G Mining Ventures Reports Strong Q3 2025 Results
Vista Gold Corp.
Vista Gold Highlights Mt Todd Milestones and Announces Third Quarter 2025 Financial Results

More Showcase News Releases »